Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects

AIMS: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension. This study compared the pharmacokinetic and pharmacodynamic properties of aliskiren in Japanese and Caucasian subjects. METHODS: In this open-label, single-centre, parallel-group, sing...

Full description

Saved in:
Bibliographic Details
Main Authors: Vaidyanathan, Sujata, Jermany, Joanne, Yeh, ChingMing, Bizot, Marie-Noelle, Camisasca, Riccardo
Format: Artigo
Language:Inglês
Published: Blackwell Science Inc 2006
Subjects:
Pharmacokinetics & Pharmacodynamics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885182/
https://ncbi.nlm.nih.gov/pubmed/17118124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02696.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items